BNP Paribas Financial Markets’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-79
| Closed | -$14 | – | 4235 |
|
|
2022
Q3 | $14 | Hold |
79
| – | – | ﹤0.01% | 3988 |
|
|
2022
Q2 | $47 | Hold |
79
| – | – | ﹤0.01% | 3396 |
|
|
2022
Q1 | $104 | Hold |
79
| – | – | ﹤0.01% | 3519 |
|
|
2021
Q4 | $206 | Sell |
79
-301
| -79% | -$785 | ﹤0.01% | 3495 |
|
|
2021
Q3 | $1.18K | Buy |
380
+79
| +26% | +$246 | ﹤0.01% | 3254 |
|
|
2021
Q2 | $1.12K | Sell |
301
-2,017
| -87% | -$7.51K | ﹤0.01% | 3332 |
|
|
2021
Q1 | $8.02K | Sell |
2,318
-921
| -28% | -$3.19K | ﹤0.01% | 3268 |
|
|
2020
Q4 | $10.9K | Sell |
3,239
-135
| -4% | -$454 | ﹤0.01% | 3262 |
|
|
2020
Q3 | $11.8K | Buy |
3,374
+2,554
| +311% | +$8.97K | ﹤0.01% | 3312 |
|
|
2020
Q2 | $3.77K | Sell |
820
-3,404
| -81% | -$15.7K | ﹤0.01% | 3470 |
|
|
2020
Q1 | $14K | Buy |
4,224
+2,334
| +123% | +$7.73K | ﹤0.01% | 3365 |
|
|
2019
Q4 | $11.5K | Buy |
1,890
+157
| +9% | +$959 | ﹤0.01% | 3442 |
|
|
2019
Q3 | $7.23K | Buy |
1,733
+1,698
| +4,851% | +$7.08K | ﹤0.01% | 3567 |
|
|
2019
Q2 | $459 | Buy |
+35
| New | +$459 | ﹤0.01% | 3785 |
|